Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DSGN | SLS | AUTL | ||
| Company | Design Therapeutics Inc | Sellas Life Sciences Group Inc | Autolus Therapeutics Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.46 | 4.45 | 2.0400 | ||
| High | 9.71 | 4.66 | 2.0400 | ||
| Low | 8.94 | 3.96 | 1.8700 | ||
| Latest | 9.10 | 4.35 | 1.8700 | ||
| Change | -0.28 | +0.58 | -0.1200 | ||
| % Change | -2.99% | +15.38% | -6.03% | ||
| Volume | 220,081 | 30,014,954 | 2,352,875 | ||
| 20-Day Average Volume | 484,684 | 10,362,131 | 2,642,219 | ||
| Previous Close | 9.38 | 3.77 | 1.9900 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.51 | 2.50 | 1.6678 | ||
| 20-Day Raw Stochastic | 36.18% | 88.08% | 74.36% | ||
| 20-Day Relative Strength | 52.80 | 86.74 | 62.22 | ||
| Weighted Alpha | +104.79 | +168.73 | -20.17 | ||
| Today's Opinion | 88% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.47% since 12/24/25 | +50.90% since 12/24/25 | +12.80% since 12/24/25 | ||
| Low | 8.94 on 01/02/26 | 2.60 on 12/29/25 | 1.6301 on 12/26/25 | ||
| High | 10.01 on 12/30/25 | 4.66 on 01/02/26 | 2.0450 on 12/31/25 | ||
| 1-Month | |||||
| %Chg | +1.90% since 12/02/25 | +208.32% since 12/02/25 | +41.42% since 12/02/25 | ||
| Low | 8.43 on 12/19/25 | 1.41 on 12/03/25 | 1.3300 on 12/03/25 | ||
| High | 10.31 on 12/05/25 | 4.66 on 01/02/26 | 2.0450 on 12/31/25 | ||
| 3-Month | |||||
| %Chg | +51.45% since 10/02/25 | +150.62% since 10/02/25 | +17.70% since 10/02/25 | ||
| Low | 5.28 on 10/22/25 | 1.39 on 12/02/25 | 1.2000 on 11/21/25 | ||
| High | 10.31 on 12/05/25 | 4.66 on 01/02/26 | 2.0450 on 12/31/25 | ||
| 6-Month | |||||
| %Chg | +147.55% since 07/02/25 | +102.15% since 07/02/25 | -19.36% since 07/02/25 | ||
| Low | 3.52 on 07/08/25 | 1.39 on 12/02/25 | 1.2000 on 11/21/25 | ||
| High | 10.31 on 12/05/25 | 4.66 on 01/02/26 | 2.7000 on 07/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 534,322 | 537,006 | 529,625 | ||
| Shares Outstanding, K | 56,964 | 142,442 | 266,143 | ||
| Annual Sales | 0 | 0 | 10,120,000 | ||
| Annual Net Income | -49,590,000 | -30,880,000 | -220,660,000 | ||
| Last Quarter Sales | 0 | 0 | 21,190,000 | ||
| Last Quarter Net Income | -17,000,000 | -6,790,000 | -79,120,000 | ||
| 60-Month Beta | 1.63 | 2.51 | 2.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 11/05/25 | -0.06 on 11/12/25 | -0.30 on 11/12/25 | ||
| Latest Earnings Date | 03/09/26 | 03/19/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||